RegionsNorth AmericaEuropeIsraelIndiaSoutheast AsiaEast AsiaLatin AmericaMiddle EastAfricaOceaniaGlobalUpdated 14 October 2026
AcquiredStartups
SearchExit tracker
Top startup acquisitions · Healthtech & bio

Top Healthtech & bio startup acquisitions in August 2026

We tracked 6 startup exits in August 2026. 3 disclosed a price, worth $3.8bn in total. The biggest was Eli Lilly buying Merida Biosciences for $2.88bn, ahead of Jazz Pharmaceuticals and Actio Biosciences at $820m.

All Healthtech & bio startup acquisitions →
  1. #DateAcquirer → StartupSectorLocationPriceSize
  2. 131 AugEli Lilly → Merida BiosciencesEli Lilly agrees to buy Merida Biosciences for up to $2.875 billionHealthtech & bioCambridge, United States$2.88bn$1bn+
  3. 210 AugJazz Pharmaceuticals → Actio BiosciencesJazz Pharmaceuticals to buy Actio Biosciences for $820 million upfrontHealthtech & bioSan Diego, United States$820m$250m–1bn
  4. 34 AugHinge Health → Cylinder HealthHinge Health to buy digestive care startup Cylinder Health for $105 millionHealthtech & bioChicago, United States$105m$50–250m
  5. 424 AugHealthify → Berry StreetBerry Street merges with Khosla-backed Healthify to build AI-assisted metabolic care in the USHealthtech & bioNew York, United StatesUndisclosedUndisclosed
  6. 519 AugKodeon → BreetheKodeon acquires Montreal meditation app Breethe in its largest deal so farHealthtech & bioMontreal, CanadaUndisclosedUndisclosed
  7. 618 AugAepsy → KinasticAepsy acquires Zurich workplace-health startup KinasticHealthtech & bioZurich, SwitzerlandUndisclosedUndisclosed